Mass spectrometry-based serum proteomic signature as a potential biomarker for survival in patients with non-small cell lung cancer receiving immunotherapy

BACKGROUND: VeriStrat test is a serum assay which uses a mass spectrometry (MS)-based proteomic signature derived from machine learning. It is currently used as a prognostic marker for patients with non-small cell lung cancer (NSCLC) receiving chemotherapy. However, little is known about its role fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chae, Young Kwang, Kim, Won Bin, Davis, Andrew A., Park, Lee Chun, Anker, Jonathan F., Simon, Nicholas I., Rhee, Kyunghoon, Song, Junho, Cho, Anderson, Chang, Sangmin, Ko, Taeyeong, Oh, Michael, Bhave, Manali, Viveiros, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481587/
https://www.ncbi.nlm.nih.gov/pubmed/32953481
http://dx.doi.org/10.21037/tlcr-20-148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481587/
https://www.ncbi.nlm.nih.gov/pubmed/32953481
http://dx.doi.org/10.21037/tlcr-20-148

Ejemplares similares